Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study.
Wu
Chia-Liang
CL
Yang
Kai-Chun
KC
Wang
Shyh-Jen
SJ
Chou
Yuan-Hwa
YH
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D050483:Dopamine Plasma Membrane Transport Proteins / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D011485:Protein Binding / Q000187:drug effects; D011618:Psychotic Disorders / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000209:etiology; D015363:Quinolones / Q000627:therapeutic use*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods
D014150:Antipsychotic Agents; D050483:Dopamine Plasma Membrane Transport Proteins; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole